申请人:Crinetics Pharmaceuticals, Inc.
公开号:US10562884B2
公开(公告)日:2020-02-18
Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.
本文描述了黑色素皮质素亚型-2 受体(MC2R)调节剂化合物、制造此类化合物的方法、包含此类化合物的药物组合物和药物,以及使用此类化合物治疗可从调节 MC2R 活性中获益的病症、疾病或紊乱的方法。